Claim · model-written summary
In growth-chamber trials, C. albidus reduced disease incidence on host plants by 43.7%.
- Taxon
- Common Bean
Phaseolus vulgarist0 - Treatment
- C. albiduse1
- Second interactor
- C. albiduse1biocontrol_agent
- Outcome
- disease incidencee1
- Direction
- reducede1
- Value
- 43.7%e1
- Setting
- Growth-chambere0
Not reportedMaterialGeneCompoundOrgan / stageInteractorInteractor roleComparatorQualifier
Organisms pictured · Representative pictures of the matched species, not figures from the paper.
Verbatim
t0“Common Bean”
e0“Growth-chamber trials”
e1“C. albidus reduced disease incidence by 43.7%”
Title
Fatma Salem; Sherif Mohamed Zaki; Ahlam Mahmoud Gowily Egyptian Journal of Botany 2025. doi:10.21608/ejbo.2025.334666.3073
Other claims from this paper (8)
- Intervention effect In the in-vitro dual culture, C. albidus showed the greatest ability to suppress S. sclerotiorum growth, with a 48.57% inhibition rate.
- Intervention effect Volatile metabolites of C. albidus inhibited the growth of S. sclerotiorum by 53.38%.
- Intervention effect Volatile metabolites of S. cerevisiae inhibited the growth of S. sclerotiorum by 44.24%.
- Intervention effect In the non-volatile metabolites assay, the first of the two isolates reached an inhibition rate of 60.93% on S. sclerotiorum.
- Intervention effect In the non-volatile metabolites assay, the second of the two isolates reached an inhibition rate of 54.49% on S. sclerotiorum.
- Intervention effect In growth-chamber trials, S. cerevisiae reduced disease incidence on host plants by 31.2%.
- Intervention effect Trials showed enhanced plant growth parameters, with increases in height and in dry and fresh weight.
- Mechanism The authors suggest that P. vulgaris plants may develop resistance against S. sclerotiorum through biological protection provided by endophytic yeasts.